Reprint of: Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells

Matrix Biology

Volumn 35, Issue , 2014, Pages 42-50

  Goyal, Atul ^a,b   Neill, Thomas ^a,b   Owens, Rick T ^c   Schaefer, Liliana ^d   Iozzo, Renato V ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c LIFECELL CORPORATION   (United States)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Decorin; IR A; Proliferation; Signaling

Indexed keywords

ADENOSINE PHOSPHATE; BECLIN 1; DECORIN; MAMMALIAN TARGET OF RAPAMYCIN; PEG3 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CELL MEMBRANE; COMPLEX FORMATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE; UMBILICAL VEIN ENDOTHELIAL CELL;

EUKARYOTA;

EID: 84901391901     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2014.04.002     Document Type: Article

References (78)

1. Alers S., Löffler A.S., Wesselborg S., Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: crosstalk, shortcuts, and feedbacks. Mol. Cell. Biol. 2012, 32:2-11.
2. Ameye L., Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002, 12:107R-116R.
3. Baghy K., Horváth Z., Regõs E., Kiss K., Schaff Z., Iozzo R.V., Kovalszky I. Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis. FEBS J. 2013, 280:2150-2164.
4. Bi X., Tong C., Dokendorff A., Banroft L., Gallagher L., Guzman-Hartman G., Iozzo R.V., Augenlicht L.H., Yang W. Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. Carcinogenesis 2008, 29:1435-1440.
5. Bi X., Pohl N.M., Yang G.R., Gou Y., Guzman G., Kajdacsy-Balla A., Iozzo R.V., Yang W. Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis 2012, 33:326-330.
6. Brandan E., Gutierrez J. Role of skeletal muscle proteoglycans during myogenesis. Matrix Biol. 2013, 32:289-297.
7. Buraschi S., Pal N., Tyler-Rubinstein N., Owens R.T., Neill T., Iozzo R.V. Decorin antagonizes Met receptor activity and downregulates β-catenin and Myc levels. J. Biol. Chem. 2010, 285:42075-42085.
8. Buraschi S., Neill T., Owens R.T., Iniguez L.A., Purkins G., Vadigepalli R., Evans B., Schaefer L., Peiper S.C., Wang Z., Iozzo R.V. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model. PLoS ONE 2012, 7:e45559.
9. Buraschi S., Neill T., Goyal A., Poluzzi C., Smythies J., Owens R.T., Schaefer L., Torres A.T., Iozzo R.V. Decorin causes autophagy in endothelial cells via Peg3. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E2582-E2591.
10. Choi A.M.K., Ryter S.W., Levine B. Autophagy in human health and disease. N. Engl. J. Med. 2013, 368:651-662.
11. Curley J.P., Pinnock S.B., Dickson S.L., Thresher R., Miyoshi N., Surani M.A., Keverne E.B. Increased body fat in mice with a targeted mutation of the paternally expressed imprinted gene Peg3. FASEB J. 2005, 19:1302-1322.
12. Dagda R., Cherra S.J.I., Kulich S.M., Tandon A., Park D., Chu C.T. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J. Biol. Chem. 2009, 284:13843-13855.
13. Dowdy S.C., Gostout B.S., Shridhar V., Wu X., Smith D.I., Podratz K.C., Jiang S.-W. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. Gynecol. Oncol. 2005, 99:126-134.
14. Du J., Teng R.-J., Guan T., Eis A., Kaul S., Konduri G.G., Shi Y. Role of autophagy in angiogenesis in aortic endothelial cells. Am. J. Physiol. Cell Physiol. 2012, 302:C383-C391.
15. Duncan M.B. Extracellular matrix transcriptome dynamics in hepatocellular carcinoma. Matrix Biol. 2013, 32:393-398.
16. Dunkman A.A., Buckley M.R., Mienaltowski M.J., Adams S.M., Thomas S.J., Satchell L., Kumar A., Pathmanathan L., Beason D.P., Iozzo R.V., Birk D.E., Soslowsky L.J. Decorin expression is important for age-related changes in tendon structure and mechanical properties. Matrix Biol. 2013, 32:3-13.
17. Feng W., Marquez R.T., Lu Z., Liu J., Lu K.H., Issa J.-P.J., Fishman D.M., Yu Y., Bast R.C. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 2008, 112:1489-1502.
18. Ferdous Z., Wei V.M., Iozzo R.V., Höök M., Grande-Allen K.J. Decorin-transforming growth factor-ß interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. J. Biol. Chem. 2007, 282:35887-35898.
19. Frey T., Schroeder N., Manon-Jensen T., Iozzo R.V., Schaefer L. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J. 2013, 280:2165-2179.
20. Funderburk S.F., Wang Q.J., Yue Z. The Beclin 1-VPS34 complex - at the crossroads of autophagy and beyond. Trends Cell Biol. 2010, 20:355-362.
21. Goldoni S., Iozzo R.V. Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int. J. Cancer 2008, 123:2473-2479.
22. Goldoni S., Owens R.T., McQuillan D.J., Shriver Z., Sasisekharan R., Birk D.E., Campbell S., Iozzo R.V. Biologically active decorin is a monomer in solution. J. Biol. Chem. 2004, 279:6606-6612.
23. Goldoni S., Seidler D.G., Heath J., Fassan M., Baffa R., Thakur M.L., Owens R.A., McQuillan D.J., Iozzo R.V. An anti-metastatic role for decorin in breast cancer. Am. J. Pathol. 2008, 173:844-855.
24. Goldoni S., Humphries A., Nyström A., Sattar S., Owens R.T., McQuillan D.J., Ireton K., Iozzo R.V. Decorin is a novel antagonistic ligand of the Met receptor. J. Cell Biol. 2009, 185:743-754.
25. Goyal A., Poluzzi C., Willis A.C., Smythies J., Shellard A., Neill T., Iozzo R.V. Endorepellin affects angiogenesis by antagonizing diverse VEGFR2-evoked signaling pathways: transcriptional repression of HIF-1α and VEGFA and concurrent inhibition of NFAT1 activation. J. Biol. Chem. 2012, 287:43543-43556.
26. Grant D.S., Yenisey C., Rose R.W., Tootell M., Santra M., Iozzo R.V. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002, 21:4765-4777.
27. Häkkinen L., Strassburger S., Kahari V.M., Scott P.G., Eichstetter I., Iozzo R.V., Larjava H. A role for decorin in the structural organization of periodontal ligament. Lab. Invest. 2000, 80:1869-1880.
28. Horváth Z., Kovalszky I., Fullár A., Kiss K., Schaff Z., Iozzo R.V., Baghy K. Decorin deficiency promotes hepatic carcinogenesis. Matrix Biol. 2013, 33. 10.1016/j.matbio.2013.11.004.
29. Ichii M., Frank M.B., Iozzo R.V., Kincade P.W. The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. Blood 2012, 119:1683-1692.
30. Iozzo R.V., Cohen I. Altered proteoglycan gene expression and the tumor stroma. Cell. Mol. Life Sci. 1993, 49:447-455.
31. Iozzo R.V., Sanderson R.D. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell. Mol. Med. 2011, 15:1013-1031.
32. Iozzo R.V., Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J. 2010, 277:3864-3875.
33. Iozzo R.V., Chakrani F., Perrotti D., McQuillan D.J., Skorski T., Calabretta B., Eichstetter I. Cooperative action of germline mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:3092-3097.
34. Iozzo R.V., Moscatello D., McQuillan D.J., Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 1999, 274:4489-4492.
35. Iozzo R.V., Buraschi S., Genua M., Xu S.-Q., Solomides C.C., Peiper S.C., Gomella L.G., Owens R.T., Morrione A. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J. Biol. Chem. 2011, 286:34712-34721.
36. Iozzo R.V., Goldoni S., Berendsen A., Young M.F. Small leucine-rich proteoglycans. Extracellular Matrix: An Overview 2011, 197-231. Springer. R.P. Mecham (Ed.).
37. Järveläinen H., Puolakkainen P., Pakkanen S., Brown E.L., Höök M., Iozzo R.V., Sage H., Wight T.N. A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen. 2006, 14:443-452.
38. Jiang X., Yu Y., Yang H.W., Agar N.Y.R., Frado L., Johnson M.D. The imprinted gene PEG3 inhibits Wnt signaling and regulates glioma growth. J. Biol. Chem. 2010, 285:8472-8480.
39. Karamanos N.K., Tzanakakis G.N. Glycosaminoglycans: from "cellular glue" to novel therapeutical agents. Curr. Opin. Pharmacol. 2012, 12:220-222.
40. Khan G.A., Girish G.V., Lala N., DiGuglielmo G.M., Lala P.K. Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast. Mol. Endocrinol. 2011, 25:1431-1443.
41. Kim J., Kundu M., Viollet B., Guan K.-L. AMPK and mTOR regulate autophagy through direct phopshorylation of Ulk1. Nat. Cell Biol. 2011, 13:132-141.
42. Kuhajda F.P. AMP-activated protein kinase and human cancer: cancer metabolism revisited. Int. J. Obes. 2008, 32:536-541.
43. Lee D.H., Shi J., Jeoung N.H., Kim M.S., Zabolotny J.M., Lee S.W., White M.F., Wei L., Kim B.-K. Targeted disruption of ROCK1 causes insulin resistance in vivo. J. Biol. Chem. 2009, 284:11776-11780.
44. Lee J.W., Park S., Takahashi Y., Wang H.-G. The association of AMPK with ULK1 regulates autophagy. PLoS ONE 2010, 5:e15394.
45. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
46. Liang J., Milson C. AMPK: a contextual oncogene or tumor suppressor?. Cancer Res. 2013, 73:2929-2935.
47. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by Beclin 1. Nature 1999, 402:672-676.
48. Liu J., Xia H., Kim M., Xu L., Li Y., Zhang L., Cai Y., Norber H.V., Zhang T., Furuya T., Jin M., Zhu Z., Wang H., Yu J., Li Y., Hao Y., Choi A., Ke H., Ma D., Yuan J. Beclin 1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011, 147:223-234.
49. Maegawa S., Yoshioka H., Itaba N., Kubota N., Nishihara S., Shirayoshi Y., Nanba E., Oshimura M. Epigenetic silencing of PEG3 gene expression in human glioma cell lines. Mol. Carcinog. 2001, 31:1-9.
50. Merline R., Lazaroski S., Babelova A., Tsalastra-Greul W., Pfeilschifter J., Schluter K.D., Gunther A., Iozzo R.V., Schaefer R.M., Schaefer L. Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. J. Physiol. Pharmacol. 2009, 60(Suppl. 4):5-13.
51. Merline R., Moreth K., Beckmann J., Nastase M.V., Zeng-Brouwers J., Tralhão J.G., Lemarchand P., Pfeilschifter J., Schaefer R.M., Iozzo R.V., Schaefer L. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and microRNA-21. Sci. Signal. 2011, 4:ra75.
52. Merline R., Nastase M.V., Iozzo R.V., Schaefer L. Small leucine-rich proteoglycans: multifunctional signaling effectors. Extracellular Matrix: Pathobiology and Signaling 2012, 185-196. Walter de Gruytier Gmbh and Co., Berlin. N. Karamanos (Ed.).
53. Minor K.H., Bournat J.C., Toscano N., Giger R.J., Davies S.J.A. Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue. Brain 2011, 134:1140-1155.
54. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
55. Morrione A., Neill T., Iozzo R.V. Dichotomy of decorin activity on the insulin-like growth factor-I system. FEBS J. 2013, 280:2138-2149.
56. Neill T., Painter H., Buraschi S., Owens R.T., Lisanti M.P., Schaefer L., Iozzo R.V. Decorin antagonizes the angiogenic network. Concurrent inhibition of Met, hipoxia inducible factor-1α and vascular endothelial growth factor A and induction of thrombospondin-1 and TIMP3. J. Biol. Chem. 2012, 287:5492-5506.
57. Neill T., Schaefer L., Iozzo R.V. Decorin, a guardian from the matrix. Am. J. Pathol. 2012, 181:380-387.
58. Neill T., Jones H.R., Crane-Smith Z., Owens R.T., Schaefer L., Iozzo R.V. Decorin evokes rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho-associated coiled-coil containing protein kinase 1. FEBS J. 2013, 280:2353-2368.
59. Neill T., Torres A.T., Buraschi S., Iozzo R.V. Decorin has an appetite for endothelial cell autophagy. Autophagy 2013, 9:1626-1628.
60. Nikitovic D., Aggelidakis J., Young M.F., Iozzo R.V., Karamanos N.K., Tzanakakis G.N. The biology of small leucine-rich proteoglycans in bone pathophysiology. J. Biol. Chem. 2012, 287:33926-33933.
61. Pattingre S., Levine B. Bcl-2 inhibition of autophagy: a new route to cancer?. Cancer Res. 2006, 66:2885-2888.
62. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
63. Reed C.C., Iozzo R.V. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj. J. 2002, 19:249-255.
64. Reed C.C., Gauldie J., Iozzo R.V. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene 2002, 21:3688-3695.
65. Reed C.C., Waterhouse A., Kirby S., Kay P., Owens R.A., McQuillan D.J., Iozzo R.V. Decorin prevents metastatic spreading of breast cancer. Oncogene 2005, 24:1104-1110.
66. Reese S.P., Underwood C.J., Weiss J.A. Effects of decorin proteoglycan on fibrillogenesis, ultrastructure, and mechanics of type I collagen gels. Matrix Biol. 2013, 32:414-423.
67. Robinson P.S., Huang T.F., Kazam E., Iozzo R.V., Birk D.E., Soslowsky L.J. Influence of decorin and biglycan on mechanical properties of multiple tendons in knockout mice. J. Biomech. Eng. 2005, 127:181-185.
68. Rubinsztein D.C., Codogno P., Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 2012, 11:709-730.
69. Rühland C., Schönherr E., Robenek H., Hansen U., Iozzo R.V., Bruckner P., Seidler D.G. The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis. FEBS J. 2007, 274:4246-4255.
70. Santra M., Mann D.M., Mercer E.W., Skorski T., Calabretta B., Iozzo R.V. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 1997, 100:149-157.
71. Santra M., Eichstetter I., Iozzo R.V. An anti-oncogenic role for decorin: downregulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J. Biol. Chem. 2000, 275:35153-35161.
72. Schaefer L., Iozzo R.V. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J. Biol. Chem. 2008, 283:21305-21309.
73. Schaefer L., Iozzo R.V. Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. Curr. Opin. Genet. Dev. 2012, 22:56-57.
74. KIP1. J. Biol. Chem. 2001, 276:40687-40692.
75. Schönherr E., Sunderkotter C., Schaefer L., Thanos S., Grässel S., Oldberg Å., Iozzo R.V., Young M.F., Kresse H. Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J. Vasc. Res. 2004, 41:499-508.
76. Waf1. Blood 2001, 98:2124-2133.
77. Zhang G., Chen S., Goldoni S., Calder B.W., Simpson H.C., Owens R.T., McQuillan D.J., Young M.F., Iozzo R.V., Birk D.E. Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J. Biol. Chem. 2009, 284:8888-8897.
78. Zoeller J.J., Pimtong W., Corby H., Goldoni S., Iozzo A.E., Owens R.T., Ho S.-Y., Iozzo R.V. A central role for decorin during vertebrate convergent extension. J. Biol. Chem. 2009, 284:11728-11737.